Viela Bio, Inc. announced that pursuant to the Merger Agreement, effective immediately after the Effective Time, each of (i) Zhengbin (Bing) Yao, Ph.D., Yanling Cao, Edward Hu, Rachelle Jacques, Chris Nolet, Tyrell Rivers, Ph.D. and Andreas Wicki, Ph.D. ceased serving as a member of the board of directors of the Company and each committee thereof and (ii) Dr. Yao, Mitchell Chan, J rn Drappa, M.D., Ph.D. and William Ragatz ceased serving as an officer of the Company. Further, pursuant to the Merger Agreement and effective immediately after the Effective Time, Timothy P. Walbert and Paul W. Hoelscher, the members of the board of directors of, and President and Treasurer, respectively, of Purchaser immediately prior to the Effective Time, became the members of the board of directors and officers of the Company, holding the same positions.